01 / 05
The “ADHD Epidemic” Is Just an Overdiagnosis Epidemic

Blog Post | Mental Health

The “ADHD Epidemic” Is Just an Overdiagnosis Epidemic

Screen time gets the blame, but the increase in diagnoses comes more from subjective criteria interacting with financial incentives.

Summary: The rapid rise in ADHD diagnoses reflects expanding diagnostic criteria and financial incentives as much as any increase in impairment. Traits such as distractibility, high activity, and shifting attention often represent ordinary developmental or cognitive variation, especially among children expected to conform to rigid classroom routines. Digital media reshapes attention rather than simply damaging it, strengthening some abilities while weakening others. More reliable diagnoses require tighter criteria, independent assessments, and systems that do not create perverse financial incentives.


The sharp increase in attention-deficit/hyperactivity disorder (ADHD) diagnoses—nearly doubling among American children between 1997 and 2022, and more than tripling among adults from 2012 to 2023—has been chalked up to better screening, increased awareness, and the corrosive effects of smartphones and social media on developing brains. None of these factors holds up well under scrutiny.

The diagnostic category itself has been steadily widened by the institutions that define it and the financial structure that rewards every participant for applying the ADHD label. As we have argued in our Cato Institute analysis of how the American healthcare system rewards psychiatric overdiagnosis, subjective diagnostic criteria interact with a payment system that rewards diagnosis to produce predictable inflation across psychiatric categories. The result is labeling ordinary behavior as pathological. ADHD is among the cleanest case studies of that pattern.

Foraging minds in an industrial classroom.

Human cognition was shaped over hundreds of thousands of years in small foraging bands, where attentional flexibility was an asset rather than a liability. A child who scanned the horizon, registered novel stimuli, and shifted focus rapidly between threats and opportunities was a child more likely to survive. Sustained, narrowly channeled attention to a single abstract task for hours at a time was simply not part of the ancestral environment, and the cognitive machinery to produce such concentration on demand was never uniformly selected for. What we now call distractibility is, in another light, vigilance. Most animals, including ancestral humans, evolved to be constantly on the lookout for novelty and threat.

Mass schooling, which emerged in the 19th century in part to prepare children for industrial labor, asks something quite different. It asks 6- and 7‑year-olds to sit still in rows, suppress physical movement, attend to a single voice for extended stretches, and produce written output on a fixed schedule. Most children adapt. The variance in how easily they do so is enormous, and the children at the lower tail of conformity to that demand have come to define the diagnostic category.

Boys end up there more often than girls, for reasons that are not mysterious. Boys, on average, are more physically active, take longer to develop self-control, and are more drawn to rough play. The same pattern shows up in other mammals and tracks the effects of testosterone on brain development. Put boys in a room and tell them to sit still for six hours, and a predictable share of them will fail, not because they are mentally ill but because they are boys. The youngest children in any classroom are also more likely to be diagnosed with ADHD than their older peers, a finding so robust across studies and countries that it points to ordinary developmental variation rather than disease.

The evolutionary frame also provides a more nuanced understanding of the fear that screen time in childhood harms brain development and attention span. The brain is plastic, especially in childhood, and it adapts to the environment it is given. That plasticity is precisely what allowed generations raised under modern industrialized education systems to develop the sustained attention style that schools reward, despite it being so far from our environment of evolutionary adaptedness. But a generation that grows up navigating fast-moving feeds, switching between applications, and processing rapid streams of visual information will predictably develop a different attentional profile than one raised on books and chalkboards.

That does not mean the learning or attention span of youth raised on digital technology is impaired. Heavy media multitaskers and habitual users of touchscreen devices do tend to perform worse on tasks that demand sustained, narrowly focused attention and inhibitory control. But they also tend to perform better on tasks that demand rapid visual search, parallel processing of multiple objects, and flexible reallocation of attention. Action video game play, in particular, has been shown to enhance visual selective attention, processing speed, and the spatial resolution of vision. These effects transfer beyond the trained task, improving general abilities to track several moving things at once, spot relevant objects in a crowded scene, and pick out a target faster when surrounded by distractions.

These cognitive trade-offs elucidate how neural plasticity gives rise to different forms of intelligence. The brain has a finite budget of computational and metabolic resources, and the cortex reallocates them in response to the demands placed on it. The clearest demonstrations come from sensory deprivation: In people who lose their sight, the visual cortex does not simply lie fallow but is recruited for auditory and tactile processing, including Braille reading, with measurable gains in those domains. Congenitally deaf individuals show analogous repurposing of the auditory cortex for vision and smell. Every brain is continuously specializing toward whatever it does most, and different cognitive skillsets have different trade-offs.

A brain trained on rapid feeds and parallel streams gets better at rapid visual search, switching, and parallel processing while getting worse at slow, serial, endogenous focus. A brain trained on long books and chalkboards makes the opposite trade. The picture is not simply that screens damage children’s brains or lower their intelligence. Claims of generalized cognitive harm typically rest on measures of a single attentional style, the one schools happen to demand, and ignore the capacities that grow on the other side of the ledger. Calling the resulting attentional profile ADHD, treating it as a chronic illness, and medicating it accordingly is a category error. The trade-offs are real, but the diagnostic system measures only the deficits because only the deficits are reimbursable.

From hyperkinetic boys to inattentive adults.

The diagnostic category we now call ADHD has been progressively widened almost from the moment it entered the Diagnostic and Statistical Manual of Mental Disorders, the reference text published by the American Psychiatric Association that defines the criteria for every recognized psychiatric condition in the United States. The DSM-II, published in 1968, listed the condition as “hyperkinetic reaction of childhood” and described it in a single sentence, focused on the restless, disruptive child, almost always identified as a boy, who would supposedly grow out of the condition by adolescence. The DSM-III, in 1980, renamed it attention deficit disorder, with or without hyperactivity, and for the first time treated inattention as a stand-alone presentation rather than a symptom of restlessness. That single revision opened the category to a far larger population of children, especially girls, whose attentional patterns had previously been invisible to the diagnostic system.

The DSM-III‑R, in 1987, folded the subtypes back together and introduced the current acronym, ADHD. The DSM-IV, in 1994, separated the disorder again into three presentations—predominantly inattentive, predominantly hyperactive-impulsive, and combined—and explicitly extended the diagnosis into social, academic, and vocational contexts beyond childhood. Studies comparing the DSM-III‑R and DSM-IV criteria directly found that prevalence rose from 9.6 to 17.8 percent under one set of comparisons and from 7.3 to 11.4 percent under another, almost entirely on the strength of newly identified inattentive cases. The DSM‑5, in 2013, raised the age-of-onset requirement from 7 to 12 and lowered the symptom threshold for adults.

Each revision expanded the population eligible for diagnosis, and, with it, the population eligible for stimulant prescriptions, academic accommodations, and disability protections. The trajectory runs in one direction. There is no edition of the DSM in which the criteria for ADHD became more restrictive.

The incentive problem.

Layered atop the definitional and developmental story is a set of economic incentives that quietly lower the threshold for diagnosis. A growing share of these diagnoses now comes from primary care clinicians rather than specialists, reflecting how rapidly ADHD treatment has migrated into routine primary care, and how the expansion of telehealth lowered the friction of obtaining a prescription.

One of the clearest examples of incentives for overdiagnosis comes from how we finance education. When special-education funding is tied to specific diagnoses, schools have a built-in reason to identify more students with ADHD, because the label unlocks additional resources. Researchers have documented systematic differences in diagnosis and treatment that align with funding formulas rather than with underlying disease rates, a pattern consistent with third-party financial incentives shaping who gets labeled. Clinicians do not work in isolation; they respond to expectations from schools, families, and the broader system. Once stakeholders recognize that a diagnosis unlocks services, pressure to apply the label tends to grow.

Primary care clinicians typically practice in fee-for-service systems, where assigning a diagnosis makes the encounter billable and enables reimbursement for follow-up visits and medication management. Patients have their own incentives to seek the diagnosis, including academic accommodations, workplace protections, and access to performance-enhancing stimulants such as Adderall. In an environment where the condition is defined by subjective criteria rather than objective tests, it is unsurprising that some individuals exaggerate or feign symptoms to obtain those benefits.

The pattern is by now familiar. As we documented in our analysis of Medicaid-funded autism therapy, the broadening of autism criteria, combined with open-ended reimbursement, produced an explosion in spending on applied behavior analysis that far outpaced any plausible change in the prevalence of disabling autism. The broadening of ADHD criteria has produced a parallel surge in stimulant prescriptions, and our recent piece against the campaign to formalize “social media addiction” anticipates the same trajectory if that diagnosis is formalized. In each case, subjective diagnosis and financial incentives that reward diagnosis push the boundaries of illness outward.

What this should teach us.

The growth in diagnoses is best understood as the cumulative output of several systems, each behaving in a way its incentives reward. Definitions expand because there is little institutional pressure to keep them tight. Clinicians diagnose because diagnosis is what the system pays for. Schools refer because referrals bring resources. Patients seek labels because labels bring access to special accommodations. The aggregate effect is a steady erosion of the line between ordinary human variation and clinical disease.

That erosion has costs. Children whose ordinary inattentiveness is medicated as a chronic condition, adults who organize their identities around a label, and patients with severely impairing ADHD whose treatment resources are diluted across an ever-larger pool all bear those costs. The path to more reliable diagnoses runs through more reliable incentives: tighter criteria, independent assessments, and payment structures that do not reward expanding the definition of illness. Policymakers should stop structuring schools, insurers, and healthcare systems so that people must acquire a medical diagnosis to receive help, accommodations, or reimbursement.

Children today have greater safety, resource availability, and tools for education than any cohort in human history. It is the schoolroom that asks kids to sit still for hours and the diagnostic system that pathologizes the ones who cannot that are the more unusual and pathological features of modernity. A more honest accounting would distinguish severely impairing attentional disorders from the wider band of ordinary human variation. It would recognize that the temperaments now most likely to be medicalized are, in a different setting, the temperaments that helped aid survival and human progress.

This article originally appeared in The Dispatch on 5/13/2026.

NBC News | Noncommunicable Disease

Gene-Edited Beagles Could Help Dog-Allergy Sufferers

“Earlier this month, Kindred Companion Sciences, a biotech start-up based in New York, revealed that it had used the technique known as CRISPR to create the first gene-edited, hypoallergenic dogs. Thanks to a single genetic tweak, the dogs — two undeniably adorable beagles — appear unable to produce a protein that can leave some people red-eyed and wheezing.

Still, it’s a long way from the lab to the laps of pet owners across America. (It’s been two and a half years since scientists announced a gene-edited, hypoallergenic cat, but such felines are not yet available to the public.) More time and data are needed to determine whether Kindred has truly delivered on its promise of hypoallergenic dogs, experts said.”

From NBC News.

Blog Post | Population Growth

The Overpopulation Panic Dates Back to Odysseus’s Time

The Trojan War was, according to one ancient account, a population-control measure by Zeus.

Summary: Overpopulation fears date back to ancient Greece, when the Trojan War was portrayed as Zeus’s solution to excessive population. Though understandable in a preindustrial world, such anxieties became outdated as technology expanded humanity’s productive capacity. Yet Malthusian ideas still shape policies and environmental rhetoric despite improving technology and falling fertility rates.


The Odyssey is giving today’s moviegoing audiences a glimpse into the myths of the distant past, but one of the most surprising ideas in the Homeric tradition feels decidedly modern: overpopulation.

In Greek mythology, the Trojan War was a deadly conflict that Zeus orchestrated to fight human overpopulation. According to a surviving fragment of The Cypria (a prequel to Homer’s Iliad and Odyssey):

There was a time when the countless tribes of men, though wide-dispersed, oppressed the surface of the deep-bosomed earth, and Zeus saw it and had pity and in his wise heart resolved to relieve the all-nurturing earth of men by causing the great struggle of the Trojan War, that the load of death might empty the world. And so the heroes were slain in Troy, and the plan of Zeus came to pass.

Many today might sympathize with aspects of that rationale. A study published recently in thejournal Sustainable Development recommends that humanity aim to more than halve the global population, to about 4 billion, in order to improve long-term sustainability. A 2026 poll by YouGov, meanwhile, suggests that over 60 percent of Americans see overpopulation as a big problem globally and are concerned about straining the world’s resources. Such anxieties about overpopulation are far older than most realize.

The Cypria was probably composed in the late seventh century B.C. During that era, the population of the Earth is estimated to have been only between 50 million and 100 million: less than a third of the current U.S. population, about five to ten times less than the current Mediterranean population, and around 100 times less than the current global population. That this was imagined to be exhausting the world’s capacity to sustain life, the threshold for what constituted “overpopulation” was extraordinarily low by modern standards.

That perception reflected the technological realities of the ancient world. Agricultural yields were low, and transportation was slow and dangerous — traversing the “wine-dark sea,” as Homer calls the Mediterranean, was dreaded for good reason — while crop failures and hunger were common and feared. As Odysseus’s second-in-command, Eurylochus, opines, “All forms of death are hateful to wretched mortals, but to die of hunger, and so meet one’s doom, is the most pitiful.”

For most of history, additional people meant additional mouths to feed, not additional productive capacity. In this respect, the world changed remarkably little between the age of Homer and the dawn of the Industrial Revolution. When Thomas Malthus published An Essay on the Principle of Population in 1798, almost two and a half millennia after The Cypria’s composition, he articulated essentially the same fear that had motivated Zeus in the old epic tradition: Left unchecked, population would eventually outgrow the resources available to sustain it. Yet even as Malthus was composing his essay, the Industrial Revolution was transforming humanity’s relationship with nature. Mechanization, scientific agriculture, improved transportation, and later advances in medicine and sanitation meant that, for the first time, technological progress was increasing productive capacity faster than population growth.

The ancient fear of population growth outpacing resources was understandable in a world of stagnant technology. It became far less compelling in a world where human ingenuity could continually redefine the limits imposed by nature. Tragically, however, that original fear shaped destructive policies long after technological progress had undermined its underlying assumptions. China’s one-child (1979–2015) and two-child (2016–2021) policies, for example, were rationalized based on this fear. They resulted in hundreds of millions of forced sterilizations as well as other grave human rights abuses.

Even today, as many countries face below-replacement fertility rates and as the world’s population is expected to peak and eventually decline, most Americans do not know that global birth rates are falling. Organizations such as Population Connection still peddle outdated overpopulation fears through teaching materials that, the group says, reach millions of students a year, while the U.N. Environment Program’s most recent Global Environment Outlook report claims that “most of the world’s nations may be considered overpopulated” and frets about resource overuse. The Sustainable Development study cited above, which advocates massive population reduction, is merely the latest iteration of a long-discredited fear.

Zeus’s decision to reduce the population through war was portrayed as “wise” because increasing the world’s productive capacity lay beyond the imagination of the ancient Greeks. Living in a preindustrial economy with little sustained productivity growth, they could readily imagine that fewer people would solve scarcity but not that expanding resources would support a larger population. Today, there is no excuse for such a limiting worldview.

Globalized markets and modern technology have accomplished what even Zeus could not in the wildest dreams of the ancients. Humanity has pushed back the constraints that once seemed as fixed and inescapable as a hero’s fate in a Homeric epic. We now easily feed a population perhaps 100 times larger than the one known to the ancient Greeks. If only public wisdom would catch up.

This article originally appeared in National Review on 8/9/2026.

Fierce Biotech | Mental Health

Psychedelic Drug Wins Third Phase 3 Anxiety Trial

“Definium Therapeutics has scored a third straight phase 3 win for its LSD formula, with the psychedelic significantly alleviating anxiety symptoms and setting up an FDA filing next year.

While the Panorama trial did compare Definium’s DT120 ODT to placebo, the study also pitted the 100 μg dose against a 50 μg dose, which is meant to still be psychoactive but not produce any therapeutic benefit. Panorama enrolled 245 patients.

DT120 easily trounced placebo as it did in the phase 3 Voyage trial a month ago, reducing scores on the Hamilton Anxiety Rating Scale (HAM-A) by 9.8 points at week 12 after treatment compared to 4.7 points for the placebo.

This 5.1-point difference between the 100 μg dose and placebo beat the 3.6-point placebo-adjusted mark seen in the 52-patient 50 μg dose arm, though the 50 μg group was not powered for statistical analysis. In the previous Voyage trial, 100 µg DT120 scored a 5.4-point placebo-adjusted reduction in HAM-A score.

DT120 also notched a phase 3 win in major depressive disorder in June. The drug is given in a single eight-hour session during which patients are monitored by a chaperone who guides them through the effects.”

From Fierce Biotech.

Gavi | Vaccination

Global Mpox Stockpile to Speed Vaccine Access

“A new global mpox vaccine stockpile is set to begin operations later this month, creating a long-term mechanism to help ensure that countries facing mpox outbreaks have rapid and equitable access to vaccines.

Like existing global emergency stockpiles for yellow fever, meningitis, Ebola and cholera vaccines, the mpox stockpile will be available to any country that needs it. However, because supplies are limited and must be distributed equitably, it is designed primarily for emergency outbreak response.

Countries eligible for Gavi support receive stockpiled vaccines free of charge. Wealthier countries can access the stockpile just as quickly, but these countries must subsequently reimburse the cost of the vaccines.”

From Gavi.